BCom FACID - Sonic Healthcare CFO Director
| SKHCF Stock | USD 17.95 0.71 4.12% |
Insider
BCom FACID is CFO Director of Sonic Healthcare Limited
| Age | 64 |
| Phone | 61 2 9855 5444 |
| Web | https://www.sonichealthcare.com |
Sonic Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.1111 % which means that it generated a profit of $0.1111 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2175 %, meaning that it generated $0.2175 on every $100 dollars invested by stockholders. Sonic Healthcare's management efficiency ratios could be used to measure how well Sonic Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Matthew Gage | Precipio | 57 | |
| Gerrard Marangoni | Sona Nanotech | N/A | |
| Gary Pestano | Biodesix | 57 | |
| Mike McAlduff | Sona Nanotech | N/A | |
| BSRT MPH | RadNet Inc | N/A | |
| Ayman MD | Precipio | 39 | |
| Kulbir Singh | Sona Nanotech | N/A | |
| Darren Rowles | Sona Nanotech | 43 | |
| Claire Sears | Neuronetics | N/A | |
| Maria JD | bioAffinity Technologies Warran | 68 | |
| Matt Stauffer | Biodesix | N/A | |
| BBus CA | Intelligent Bio Solutions | 60 | |
| Miri ChikoRadomski | Precipio | N/A | |
| Billy White | ProPhase Labs | 63 | |
| Andrew Macan | Neuronetics | 51 | |
| Heinrich Rder | Biodesix | N/A | |
| Jeffrey Bojar | Biodesix | N/A | |
| Kara Thornton | Neuronetics | N/A | |
| Ruth VilligerWilson | RadNet Inc | 60 | |
| Ryan Siurek | Biodesix | 52 | |
| Keith Meadors | Precipio | N/A | |
Management Performance
| Return On Equity | 0.22 | |||
| Return On Asset | 0.11 |
Sonic Healthcare Leadership Team
Elected by the shareholders, the Sonic Healthcare's board of directors comprises two types of representatives: Sonic Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sonic. The board's role is to monitor Sonic Healthcare's management team and ensure that shareholders' interests are well served. Sonic Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sonic Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephen Fairy, Global Officer | ||
| Julian Adler, Chief Imaging | ||
| Mrs Schottdorf, Chief Group | ||
| FAICD FRCPA, MD CEO | ||
| BEc CA, Deputy Sec | ||
| BCom FACID, CFO Director | ||
| David Byrne, Chief Laboratory | ||
| Prashan Kulasekera, Assistant Sec | ||
| Peter Savage, Chief Officer |
Sonic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sonic Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.22 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 11.17 B | |||
| Shares Outstanding | 480.98 M | |||
| Shares Owned By Insiders | 5.09 % | |||
| Shares Owned By Institutions | 38.62 % | |||
| Price To Earning | 13.88 X | |||
| Price To Book | 1.98 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Sonic Pink Sheet
Sonic Healthcare financial ratios help investors to determine whether Sonic Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sonic with respect to the benefits of owning Sonic Healthcare security.